Literature DB >> 3839033

[Vision test program for ophthalmologists on Apple II, IIe and IIc computers].

C Huber.   

Abstract

A microcomputer program for the Apple II family of computers on a monochrome and a color screen is described. The program draws most of the tests used by ophthalmologists, and is offered as an alternative to a projector system. One advantage of the electronic generation of drawings is that true random orientation of Pflueger's E is possible. Tests are included for visual acuity (Pflueger's E, Landolt rings, numbers and children's drawings). Colored tests include a duochrome test, simple color vision tests, a fixation help with a musical background, a cobalt blue test and a Worth figure. In the astigmatic dial a mobile pointer helps to determine the axis. New tests can be programmed by the user and exchanged on disks among collageues.

Entities:  

Mesh:

Year:  1985        PMID: 3839033     DOI: 10.1055/s-2008-1050911

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  5 in total

1.  [Investigation of color vision using a web-based color vision test].

Authors:  J Kuchenbecker; T Wecke; R Wiermer; F W Röhl; H Lindner; W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2004-03       Impact factor: 1.059

Review 2.  A primer of ophthalmic computer graphics.

Authors:  L Frisén; B Lindblom
Journal:  Doc Ophthalmol       Date:  1990 Apr-Jul       Impact factor: 2.379

3.  [Validity of a web-based color vision test for screening examinations of color vision].

Authors:  J Kuchenbecker; F W Röhl; A Wesselburg; J Bernarding; W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

4.  [Visual self-assessment with the ACTO test during follow-up of AMD patients after intravitreal injections].

Authors:  A Cordes; A Strobel; C H Meyer; F Ender; N Schrage
Journal:  Ophthalmologe       Date:  2009-09       Impact factor: 1.059

Review 5.  [Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series].

Authors:  C H Meyer; H-M Helb; N Eter
Journal:  Ophthalmologe       Date:  2008-02       Impact factor: 1.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.